According to the warning letter, Medtronic failed to correct a flaw in its SynchroMed II infusion pump and properly document and investigate more than 560 complaints about the device.
Medtronic is working to resolve the complaints and implement corrective action to improve its investigative process, according to a company spokeswoman.
More Articles on Devices:
TransCorp Spine Granted U.S. Patent for SpinePort MIS Access System
